Lazard Capital Downgrades Abiomed (ABMD) to Hold
ABMD Hot Sheet
Rating Summary:4 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 1 | Down: 2 | New: 2
Lazard Capital downgrades Abiomed (Nasdaq: ABMD) from Buy to Hold.
To see more analyst ratings on ABMD Click Here.
Abiomed Inc. is a provider of medical devices in circulatory support that offers a continuum of care in heart recovery to heart failure patients.
To see more analyst ratings on ABMD Click Here.
Abiomed Inc. is a provider of medical devices in circulatory support that offers a continuum of care in heart recovery to heart failure patients.
You May Also Be Interested In
- UPDATE: UBS Downgrades Wisconsin Energy (WEC) to Neutral; Taking Some Off The Table
- Canaccord Genuity Downgrades Mercer International (MERC) to Hold
- Barclays on U.S. REITs: Best Ideas List: Adding HPP; Removing ARE
Create E-mail Alert Related Categories
DowngradesRelated Entities
LazardSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
